• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Novel insights on thyroid-stimulating hormone receptor signal transduction.促甲状腺激素受体信号转导的新见解。
Endocr Rev. 2013 Oct;34(5):691-724. doi: 10.1210/er.2012-1072. Epub 2013 May 3.
2
Structural-Functional Features of the Thyrotropin Receptor: A Class A G-Protein-Coupled Receptor at Work.促甲状腺激素受体的结构功能特征:发挥作用的A类G蛋白偶联受体
Front Endocrinol (Lausanne). 2017 Apr 24;8:86. doi: 10.3389/fendo.2017.00086. eCollection 2017.
3
Thyrotropin and homologous glycoprotein hormone receptors: structural and functional aspects of extracellular signaling mechanisms.促甲状腺激素及同源糖蛋白激素受体:细胞外信号传导机制的结构与功能方面
Endocr Rev. 2009 Apr;30(2):133-51. doi: 10.1210/er.2008-0044. Epub 2009 Jan 27.
4
The hinge region of the TSH receptor stabilizes ligand binding and determines different signaling profiles of human and bovine TSH.促甲状腺激素受体的铰链区稳定配体结合,并决定人和牛促甲状腺激素的不同信号转导特征。
Endocrinology. 2011 Oct;152(10):3986-96. doi: 10.1210/en.2011-1389. Epub 2011 Aug 16.
5
Extended and structurally supported insights into extracellular hormone binding, signal transduction and organization of the thyrotropin receptor.深入了解促甲状腺激素受体的细胞外激素结合、信号转导和结构支持。
PLoS One. 2012;7(12):e52920. doi: 10.1371/journal.pone.0052920. Epub 2012 Dec 27.
6
Thyrotropin receptor mutations as a tool to understand thyrotropin receptor action.促甲状腺激素受体突变作为理解促甲状腺激素受体作用的一种工具。
J Mol Med (Berl). 2001 Dec;79(12):707-21. doi: 10.1007/s001090100279. Epub 2001 Sep 12.
7
Central dogma in thyroid dysfunction: a review on structure modification of TSHR as a cornerstone for thyroid abnormalities.甲状腺功能障碍的中心法则:关于促甲状腺激素受体结构修饰作为甲状腺异常基石的综述
Pak J Biol Sci. 2011 Feb 1;14(3):170-81. doi: 10.3923/pjbs.2011.170.181.
8
The Molecular Function and Clinical Role of Thyroid Stimulating Hormone Receptor in Cancer Cells.甲状腺刺激素受体在癌细胞中的分子功能和临床作用。
Cells. 2020 Jul 20;9(7):1730. doi: 10.3390/cells9071730.
9
Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure-function relationships.促甲状腺激素与促甲状腺激素受体的结构-功能关系
Physiol Rev. 2002 Apr;82(2):473-502. doi: 10.1152/physrev.00031.2001.
10
Evolution of the thyrotropin receptor: a G protein coupled receptor with an intrinsic capacity to dimerize.促甲状腺激素受体的进化:一种具有内在二聚化能力的G蛋白偶联受体。
Mol Genet Metab. 2003 Apr;78(4):275-90. doi: 10.1016/s1096-7192(03)00036-2.

引用本文的文献

1
TSHR in thyroid cancer: bridging biological insights to targeted strategies.甲状腺癌中的促甲状腺激素受体:将生物学见解与靶向策略相联系
Eur Thyroid J. 2025 Jul 3;14(4). doi: 10.1530/ETJ-24-0369. Print 2025 Aug 1.
2
Monoclonal Antibodies to Thyrotropin Receptor With Thyroid-Stimulating Activity Activate the NF-κB Pathway to Induce Chemokine Expression.具有促甲状腺活性的促甲状腺素受体单克隆抗体激活NF-κB信号通路以诱导趋化因子表达。
J Cell Mol Med. 2025 Jun;29(11):e70647. doi: 10.1111/jcmm.70647.
3
Genetics of primary congenital hypothyroidism: three decades of discoveries and persisting etiological challenges.原发性先天性甲状腺功能减退症的遗传学:三十年的发现与持续存在的病因挑战
Eur Thyroid J. 2025 Mar 28;14(2). doi: 10.1530/ETJ-24-0348. Print 2025 Apr 1.
4
Exploring antigenic variation in autoimmune endocrinopathy.探索自身免疫性内分泌病中的抗原变异。
Front Immunol. 2025 Feb 28;16:1561455. doi: 10.3389/fimmu.2025.1561455. eCollection 2025.
5
Mechanisms in Thyroid Eye Disease: The TSH Receptor Interacts Directly With the IGF-1 Receptor.甲状腺眼病的发病机制:促甲状腺激素受体与胰岛素样生长因子-1受体直接相互作用。
Endocrinology. 2025 Jan 6;166(2). doi: 10.1210/endocr/bqaf009.
6
Proangiogenic effect of thyrotropin receptor stimulating antibody in human umbilical vein endothelial cells.促甲状腺素受体刺激抗体对人脐静脉内皮细胞的促血管生成作用。
Endocrine. 2025 Feb;87(2):697-706. doi: 10.1007/s12020-024-04048-z. Epub 2024 Oct 25.
7
Recombinant Human TSH Fails to Induce the Proliferation and Migration of Papillary Thyroid Carcinoma Cell Lines.重组人促甲状腺激素未能诱导甲状腺乳头状癌细胞系的增殖和迁移。
Cancers (Basel). 2024 Jul 21;16(14):2604. doi: 10.3390/cancers16142604.
8
Changing the structure of PFOA and PFOS: a chemical industry strategy or a solution to avoid thyroid-disrupting effects?改变 PFOA 和 PFOS 的结构:是化工行业的策略还是避免甲状腺干扰效应的解决方案?
J Endocrinol Invest. 2024 Aug;47(8):1863-1879. doi: 10.1007/s40618-024-02339-w. Epub 2024 Mar 24.
9
Mesenchymal Transglutaminase 2 Activates Epithelial ADAM17: Link to G-Protein-Coupled Receptor 56 (ADGRG1) Signalling.间质转谷氨酰胺酶 2 激活上皮 ADAM17:与 G 蛋白偶联受体 56(ADGRG1)信号的联系。
Int J Mol Sci. 2024 Feb 16;25(4):2329. doi: 10.3390/ijms25042329.
10
Mechanisms of thyrotropin receptor-mediated phenotype variability deciphered by gene mutations and M453T-knockin model.通过基因突变和 M453T 敲入模型解析促甲状腺激素受体介导的表型变异性的机制。
JCI Insight. 2024 Jan 9;9(4):e167092. doi: 10.1172/jci.insight.167092.

本文引用的文献

1
Relaxin family peptides and their receptors.松弛素家族肽及其受体。
Physiol Rev. 2013 Jan;93(1):405-80. doi: 10.1152/physrev.00001.2012.
2
Extended and structurally supported insights into extracellular hormone binding, signal transduction and organization of the thyrotropin receptor.深入了解促甲状腺激素受体的细胞外激素结合、信号转导和结构支持。
PLoS One. 2012;7(12):e52920. doi: 10.1371/journal.pone.0052920. Epub 2012 Dec 27.
3
Voltage regulates adrenergic receptor function.电压调节肾上腺素能受体功能。
Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1536-41. doi: 10.1073/pnas.1212656110. Epub 2013 Jan 7.
4
A pharmacological organization of G protein-coupled receptors.G 蛋白偶联受体的药理学组织。
Nat Methods. 2013 Feb;10(2):140-6. doi: 10.1038/nmeth.2324. Epub 2013 Jan 6.
5
Single-molecule analysis of fluorescently labeled G-protein-coupled receptors reveals complexes with distinct dynamics and organization.单分子荧光标记 G 蛋白偶联受体分析揭示了具有不同动力学和组织的复合物。
Proc Natl Acad Sci U S A. 2013 Jan 8;110(2):743-8. doi: 10.1073/pnas.1205798110. Epub 2012 Dec 24.
6
Molecular alliance-from orthosteric and allosteric ligands to dualsteric/bitopic agonists at G protein coupled receptors.从 G 蛋白偶联受体的变构和变构配体到双体/双位点激动剂的分子联盟。
Angew Chem Int Ed Engl. 2013 Jan 7;52(2):508-16. doi: 10.1002/anie.201205315. Epub 2012 Dec 6.
7
Current loss-of-function mutations in the thyrotropin receptor gene: when to investigate, clinical effects, and treatment.促甲状腺激素受体基因目前的功能丧失性突变:何时进行检测、临床影响及治疗
J Clin Res Pediatr Endocrinol. 2013;5 Suppl 1(Suppl 1):29-39. doi: 10.4274/jcrpe.864. Epub 2012 Nov 15.
8
Identification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A·mGlu2) receptor heteromerization and its psychoactive behavioral function.鉴定三个对 5-羟色胺 2A-代谢型谷氨酸 2(5-HT2A·mGlu2)受体异源三聚体形成及其精神活性行为功能至关重要的残基。
J Biol Chem. 2012 Dec 28;287(53):44301-19. doi: 10.1074/jbc.M112.413161. Epub 2012 Nov 5.
9
Update in TSH receptor agonists and antagonists.促甲状腺激素受体激动剂和拮抗剂的最新进展。
J Clin Endocrinol Metab. 2012 Dec;97(12):4287-92. doi: 10.1210/jc.2012-3080. Epub 2012 Sep 27.
10
Dominant negative effect of mutated thyroid stimulating hormone receptor (P556L) causes hypothyroidism in C.RF-Tshr(hyt/wild) mice.突变型促甲状腺激素受体(P556L)的显性负效应导致 C.RF-Tshr(hyt/wild) 小鼠发生甲状腺功能减退症。
PLoS One. 2012;7(8):e42358. doi: 10.1371/journal.pone.0042358. Epub 2012 Aug 16.

促甲状腺激素受体信号转导的新见解。

Novel insights on thyroid-stimulating hormone receptor signal transduction.

作者信息

Kleinau Gunnar, Neumann Susanne, Grüters Annette, Krude Heiko, Biebermann Heike

机构信息

Institute of Experimental Pediatric Endocrinology, Charité-Universitätsmedizin Berlin, Ostring 3, Augustenburger Platz 1, 13353 Berlin, Germany.

出版信息

Endocr Rev. 2013 Oct;34(5):691-724. doi: 10.1210/er.2012-1072. Epub 2013 May 3.

DOI:10.1210/er.2012-1072
PMID:23645907
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3785642/
Abstract

The TSH receptor (TSHR) is a member of the glycoprotein hormone receptors, a subfamily of family A G protein-coupled receptors. The TSHR is of great importance for the growth and function of the thyroid gland. The TSHR and its endogenous ligand TSH are pivotal proteins with respect to a variety of physiological functions and malfunctions. The molecular events of TSHR regulation can be summarized as a process of signal transduction, including signal reception, conversion, and amplification. The steps during signal transduction from the extra- to the intracellular sites of the cell are not yet comprehensively understood. However, essential new insights have been achieved in recent years on the interrelated mechanisms at the extracellular region, the transmembrane domain, and intracellular components. This review contains a critical summary of available knowledge of the molecular mechanisms of signal transduction at the TSHR, for example, the key amino acids involved in hormone binding or in the structural conformational changes that lead to G protein activation or signaling regulation. Aspects of TSHR oligomerization, signaling promiscuity, signaling selectivity, phenotypes of genetic variations, and potential extrathyroidal receptor activity are also considered, because these are relevant to an understanding of the overall function of the TSHR, including physiological, pathophysiological, and pharmacological perspectives. Directions for future research are discussed.

摘要

促甲状腺激素受体(TSHR)是糖蛋白激素受体家族的成员,属于A类G蛋白偶联受体亚家族。TSHR对甲状腺的生长和功能至关重要。TSHR及其内源性配体促甲状腺激素(TSH)在多种生理功能和功能异常方面都是关键蛋白。TSHR调节的分子事件可概括为一个信号转导过程,包括信号接收、转换和放大。从细胞外到细胞内位点的信号转导步骤尚未完全明了。然而,近年来在细胞外区域、跨膜结构域和细胞内成分的相关机制方面已取得了重要的新见解。本综述对TSHR信号转导分子机制的现有知识进行了批判性总结,例如,参与激素结合或导致G蛋白激活或信号调节的结构构象变化的关键氨基酸。还考虑了TSHR寡聚化、信号混杂性、信号选择性、基因变异表型以及潜在的甲状腺外受体活性等方面,因为这些与理解TSHR的整体功能相关,包括生理、病理生理和药理学角度。讨论了未来的研究方向。